Role of calcium signaling in Aβ42-mediated neurodegeneration in a Drosophila model of Alzheimer’s disease
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Life cycle of the fly

Calcium signaling

Alzheimer’s disease (AD) is a neurodegenerative disease that affects more
than five million individuals in the United States alone, where it is the sixth
leading cause of death. While there is currently no cure for the disease, it is a
highly investigated topic of research. The Drosophila melanogaster eye model
is an excellent system to study AD, due to the highly conserved genetic
machinery shared between flies and humans. We have developed a
transgenic fly model of AD in which we use the GAL4/UAS system to
misexpress high levels of human Aβ42 peptides in the differentiating
photoreceptor neurons in the fly eye. We use this system to determine
whether modulating the function of the calcium signaling pathway can modify
Aβ42 mediated neurodegeneration. We used RNAi to knock down six
components of the calcium signaling pathway (stimRNAi, sercaRNAi, oraiRNAi,
inx2RNAi, ip3rRNAi, and plc 21cRNAi) in an Aβ42 background in the eye and
observed the effects in both eye antennal imaginal discs and adult eyes. Our
results showed evidence that knocking down components of the calcium
signaling pathway may ameliorate the neurodegeneration mediated by Aβ42.
Aberrant calcium signaling has also been implicated in cancer and other
neurological diseases besides AD. Our research further implicates intracellular
calcium signaling in neurodegenerative disorders such as AD. Further
research will determine the molecular mechanisms linking calcium signaling
with Ab42 mediated neurodegeneration.
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Results

• Calcium is an important component for cellular signaling. Multiple
pathways control calcium concentration within the given areas.
• Alzheimer's associated peptide amyloid beta disrupts many pathways
involved in calcium signaling leading to higher calcium concentration in
the cytoplasm.
• The higher cytosolic calcium concentration potentially leads to
mitochondrial dysfunction and apoptosis.
• This contributes to the development and progression of Alzheimer's
disease.

Modeling AD in Drosophila
Healthy neuron

1,2,3,4
Singh

GMR-Gal4>Aβ42

Experimental design
Gene

Function

plc21c

Catalyzes hydrolysis of PIP2 into IP3
and DAG

orai

Located in the plasma membrane
and intakes the calcium into the
cytoplasm

stim

Regulates calcium in ER
and binds with orai to form CRAC

serca

• Alzheimer’s disease (AD) is the sixth leading cause of death in the United
States and has no known cure.
• More than 5.7 million Americans have AD.

ip3r

• Throughout the brain normal deposits of proteins form amyloid plaques and
tau tangles.

inx2

• This leads to neuronal cell death.

Gal4-UAS system

Regulates calcium intake into ER
Releases calcium from the ER into
cytoplasm
Gap junction communication

Approach: Use RNAi to knock down components of the calcium signaling
pathway in flies expressing Aβ42 in retinal neurons and determine the effects
on the eye-antennal imaginal disc and adult eye.

Why use Drosophila?
• Many genes are conserved between flies and humans.
• Flies have less genetic redundancy.
• Basic cell biological pathways are nearly identical in flies and humans (eye
specification, cell cycle, Ras, p53, InR signaling...)
• Ideal human disease model for genome wide genetic screens.

Results

Conclusions
• Downregulating the levels of expression of the six
components (stimRNAi, sercaRNAi, oraiRNAi, inx2RNAi,
ip3rRNAi, and plc 21cRNAi) of the calcium signaling
pathway demonstrated evidence of rescue of the Aβ42
phenotype in fly eye (animals reared at 29°C).
• Our results suggest that inactivation of calcium signaling
pathway may block Aβ42-mediated neurodegeneration.
• This has relevance for design of treatments for AD.
• Significance: Our studies show a role for calcium
signaling pathway in neurodegeneration disorders such
as Alzheimer's.

Future directions
1933 Thomas Hunt Morgan uncovered the role played by chromosomes in heredity
1946 Hermann Joseph Muller used X-ray irradiation to increase mutation rates in fruit flies
1995 Edward B Lewis, Christiane Nüsslein-Volhard, and Eric F Wieschaus used
drosophila to understand genetic control of embryonic development
2004 Richard Axel concentrated on odour receptors and the organisation of the olfactory
system
2011 Jules A Hoffmann for his research on the activation of innate immunity
2017 Jeffrey C Hall, Michael Rosbash and Michael W Young uncovered the molecular
mechanisms that control circadian rhythms.

• Human Aβ42 gene was inserted into the Drosophila genome
• Able to test the effect on AD, when downregulating the expression of genes
related to calcium signaling pathway.
•

Control: GMR-GAL4

• Directs expression of target transgenes in the neurons of the developing
retina.

(Caldwell et al. 2013)

• Misexpress proteins involved in calcium signaling in flies
expressing Aβ42 and determine the effect on adult eyes
and eye discs.
• Determine the mechanism of action by which the
intracellular calcium signaling pathway is involved in the
progression of Alzheimer's disease.
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